CVD is the leading cause of death globally. Between 2016 and 2035, the number of Brazilian adults with CVD will double, going from 6.2 million to 13.6 million. Meanwhile, the costs of health care and lost productivity will triple, going from US$13.7 billion in 2016 to US$40 billion by 2035. Direct costs are expected to increase at a faster rate than indirect costs, reaching US$26 billion and US$14 billion, respectively, by 2035. Without additional measures to mitigate the impact of population aging and modifiable risk factors, the burden of CVD in Brazil will only continue to grow.
In Modelling the Burden of Cardiovascular Disease in Brazil, the economic burden of cardiovascular disease (CVD) is approached from two perspectives—the direct costs of delivering health care services and their impact on the public health care system, and the indirect costs from productivity losses, which impact the broader society and economy.